title: Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathy.
authors.affiliation: St Peter's Hospital, Albany, NY carl.atkins@sphp.com.
authors.forename: Carl D
authors.initials: CD
authors.lastname: Atkins
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002118:Calcium / Q000627:therapeutic use*; D002125:Calcium Gluconate / Q000008:administration & dosage*; D003110:Colonic Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use*; D008278:Magnesium Sulfate / Q000008:administration & dosage*; D008297:Male; D018696:Neuroprotective Agents / Q000008:administration & dosage*; D020258:Neurotoxicity Syndromes / Q000517:prevention & control*; D009944:Organoplatinum Compounds / Q000009:adverse effects*; D010523:Peripheral Nervous System Diseases / Q000517:prevention & control*; D012678:Sensation Disorders / Q000517:prevention & control*
chemical_list: D000970:Antineoplastic Agents; D018696:Neuroprotective Agents; D009944:Organoplatinum Compounds; D008278:Magnesium Sulfate; D008274:Magnesium; D002125:Calcium Gluconate; D002118:Calcium